In vitro inhibition of platelets aggregation with generic form of clopidogrel versus branded in patients with stable angina pectoris
Introduction: Clopidogrel is a potent platelet activation and aggregation inhibitor that prevents thrombosis in coronary artery diseases (CADs). In comparison to locally produced generic one (Osvix®), original brand of clopidogrel (Plavix®) is expensive. This study was designed to evaluate the effec...
Main Authors: | Rza Hajizadeh, Samad Ghaffari, Mojtaba Ziaee, Behrooz Shokouhi, Ahmad Separham, Parvin Sarbakhsh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2017-12-01
|
Series: | Journal of Cardiovascular and Thoracic Research |
Subjects: | |
Online Access: | https://jcvtr.tbzmed.ac.ir/PDF/jcvtr-9-191.pdf |
Similar Items
-
ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
by: V. V. Yakusevich, et al.
Published: (2015-07-01) -
PROGNOSTIC VALUE OF P-SELECTIN IN PATIENTS WITH STABLE ANGINA PECTORIS
by: Khvysiuk M. O., et al.
Published: (2018-07-01) -
Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01) -
STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY)
by: S. V. Povetkin, et al.
Published: (2018-03-01) -
Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms
by: D F Mesitskaia, et al.
Published: (2014-09-01)